Category: Our news
Scientists at Future Health Biobank have provided samples of umbilical cord mesenchymal stem cells (MSCs), to aid pioneering research into the regeneration of tooth dentin and bone.
A recent BBC article has shone a spotlight on the “massively misdiagnosed” 22q deletion syndrome. This genetic condition can cause a range of mild to severe behavioural, psychological and physical symptoms, but often flies under the radar in babies and children.
Bern, Switzerland - September 6-7, 2018 Conference Report:
The International Stem Cell Conference / International Placenta Stem Cell Society Conference took place in Bern, Switzerland between the 6 and 7 September 2018. More than 27 presentations with speakers arriving from the USA, Australia, New Zealand, Israel, Russia, France, UK, Ukraine, Sweden, Austria, Italy, Spain and from across different universities within Switzerland.
As more and more research highlights the benefits of delayed cord clamping, it’s understandable that umbilical cord blood stem cell banking raises many questions for parents-to-be. Here we explain how delayed cord clamping works alongside cord blood stem cell banking to help protect your baby’s health.
Umbilical cord blood has been used as part of stem cell research for over 50 years. Thanks to a number of break-through scientific discoveries and successful therapies, cord blood stem cells are now an important part of standard treatments and clinical trials for a long list of diseases.
In the timeline below, find out just how far cord blood stem cell research has come so far!